Cargando…

A New and Simple Risk Predictor of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention: TIMI Risk Index

BACKGROUND: The thrombolysis in myocardial infarction risk index (TRI) was developed to estimate prognosis at the initial contact of the healthcare provider in coronary artery disease patients without laboratory parameters. In this study, we aimed to investigate the relationship of the baseline TRI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaya, Ahmet, Karataş, Ahmet, Kaya, Yasemin, Düğeroğlu, Harun, Dereli, Seçkin, Bayramoğlu, Adil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178187/ https://www.ncbi.nlm.nih.gov/pubmed/30356419 http://dx.doi.org/10.1155/2018/5908215

Ejemplares similares

The relationship between severe acute respiratory syndrome coronavirus 2 (SARS - COV - 2) pandemic and fragmented QRS
por: Bektaş, Osman, et al.
Publicado: (2020)

The effects of treatment in patients with childhood asthma on the elastic properties of the aorta
por: Bektaş, Osman, et al.
Publicado: (2017)

Color M-mode echocardiography-derived propagation velocity of descending aorta decreases with aging
por: Yaman, Mehmet, et al.
Publicado: (2017)

Dynamic TIMI Risk Score for STEMI
por: Amin, Sameer T., et al.
Publicado: (2013)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Risk factors of contrast-induced nephropathy in patients with STEMI and pump failure undergoing percutaneous coronary intervention
por: Chen, Hongwu, et al.
Publicado: (2021)

Comparison of the GRACE risk score and the TIMI risk index in predicting the extent and severity of coronary artery disease in patients with acute coronary syndrome
por: Bekler, Adem, et al.
Publicado: (2015)

Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment
por: Günaydın, Zeki Yüksel, et al.
Publicado: (2016)

TIMI perfusion grade compared to TIMI flow in prediction of infarct size and microvascular obstruction measured by contrast-enhanced MRI
por: Fuernau, Georg FK, et al.
Publicado: (2009)

Predictors of successful percutaneous transvenous mitral commissurotomy using the Bonhoeffer Multi-Track system in patients with moderate to severe mitral stenosis: Can we see beyond the Wilkins score?
por: Bektaş, Osman, et al.
Publicado: (2015)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
por: Zhang, H., et al.
Publicado: (2021)

Thyroid function among women with gestational trophoblastic diseases. A cross-sectional study
por: Düğeroğlu, Harun, et al.
Publicado: (2019)

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
por: Bergmark, Brian A., et al.
Publicado: (2018)

A simple score for the prediction of stent thrombosis in patients with ST elevation myocardial infarction: TIMI risk index
por: Çınar, Tufan, et al.
Publicado: (2019)

A clinical study about contrast nephropathy: Risk factors and the role of beta blockers
por: Akgüllü, Çağdaş, et al.
Publicado: (2015)

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions
por: Li, Wen-hua, et al.
Publicado: (2012)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study
por: Yeh, Yen-Ting, et al.
Publicado: (2016)

Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention
por: Kumar, Dileep, et al.
Publicado: (2020)

Comparison of Prediction Between TIMI (Thrombolysis in Myocardial Infarction) Risk Score and Modified TIMI Risk Score in Discharged Patients From Emergency Department With Atypical Chest Pain
por: Abbasnezhad, Mohsen, et al.
Publicado: (2014)

Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zuo, Pengfei, et al.
Publicado: (2020)

Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis
por: Wang, Jing, et al.
Publicado: (2021)

Effect of percutaneous mitral balloon valvuloplasty on right ventricular functions in mitral stenosis: Short-and mid-term results
por: Bektaş, Osman, et al.
Publicado: (2016)

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)
por: Sukmawan, Renan, et al.
Publicado: (2021)

SAVOR-TIMI to DECLARE-TIMI: A Review on Cardiovascular Outcome Trials of Incretin-modulators and Gliflozins
por: Singh, Awadhesh K., et al.
Publicado: (2019)

Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2021)

Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2020)

An Asian Validation of the TIMI Risk Score for ST-Segment Elevation Myocardial Infarction
por: Selvarajah, Sharmini, et al.
Publicado: (2012)

Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
por: HE, HAIYAN, et al.
Publicado: (2014)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019)

Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention
por: Chen, Hanchuan, et al.
Publicado: (2021)

Performance of the TIMI risk score in predicting mortality after primary percutaneous coronary intervention in elderly women: Results from a developing country
por: Furnaz, Shumaila, et al.
Publicado: (2019)

Predictors of delayed and no-reflow as recognized with Thrombolysis in Myocardial Infarction [TIMI] flow grade following Primary Percutaneous Coronary Angioplasty
por: Bahrehmand, M, et al.
Publicado: (2015)

Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
por: Aktürk, Erdal, et al.
Publicado: (2019)

The effect of Fasting during Ramadan on the Kidney functions of Stage III-IV Chronic Kidney Disease Patients
por: Karatas, Ahmet, et al.
Publicado: (2021)

Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2015)

Risk Prediction for Contrast-Induced Nephropathy in Cancer Patients Undergoing Computed Tomography under Preventive Measures
por: Jeon, Junseok, et al.
Publicado: (2019)

The prognostic value of altitude in patients with heart failure with reduced ejection fraction
por: Kaya, Ahmet, et al.
Publicado: (2019)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhu, Boqian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vuqts89lnjl1udkqinfc9aam43